Healthcare Sector's Top Losers (NAVB, ASTX, DCTH)

Los Angelas, CA -- (SBWIRE) -- 03/18/2013 -- Navidea Biopharmaceuticals Inc (NYSEAMEX:NAVB) dropped -8.25% with the closing price of $2.67. The overall volume in the last trading session was 6.84 million shares. Its fifty two week range was $2.14-$4.77. The total market capitalization remained $286.73 million.

The stock is ahead of its 52 week low 24.77% and its last month price volatility remained 5.52%. Its beta coefficient was 0.88 with a target price of $5.11. In its share capital, the company has 114.56 million outstanding shares, while 110.41 million shares have been floated in the market.

It has insider ownership of 3.86% with its institutional ownership at 24.26%. Its current year earnings per share grew 75.29%.

How To Trade NAVB Now After The Recent Volatile Moves? Find Out Here

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) is scheduled to present at the 25th Annual ROTH Conference to be held on Tuesday, March 19th, in Laguna Niguel, California. The presentation by James S.J. Manuso, PhD, chairman and chief executive officer, will begin at 6:30PM EDT.

Astex Pharmaceuticals, Inc. shares went 6.99% down and closed at $3.99 in the last trading session. Its overall traded volume was 3.77 million shares. The stock’s opening price was $4.25, hitting the day high price of $4.29 and day low of $3.93.

ASTX has earnings per share of $0.08 and its price to earnings ratio was 49.88. The company has 1.44% return on assets, 1.74% return on equity and its return on investments is 1.61%.

What Should Investors Do With ASTX Now? Find Out Here

Delcath Systems, Inc. (NASDAQ:DCTH) declined after its earnings results. In other news, its executive management is set to present at the 25th Annual ROTH Conference on Monday, March 18, 2013 at 12:00PM PT (3:00 PM ET) in Laguna Niguel, CA to provide an overview of the Company`s business strategy and recent corporate developments.

Delcath Systems, Inc. dropped -5.68% to close at $1.66 and its total volume in the last trading session was 6.33 million shares. In the last 52 weeks, high hit was $3.54 and low price in that period was $1.01.

The company has outstanding shares of 75.08 million with the total market cap of $124.63million and its beta value stands at 1.84 times. It has current ratio of 3.16.

How Should Investors Trade DCTH After The Recent Movement? Find Out Here

Disclaimer
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com